Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1920149

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1920149

North America Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others

PUBLISHED:
PAGES: 155 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

GlobalData's "North America Interventional Cardiology Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments -

The North America Interventional Cardiology Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Interventional Cardiology Market.
  • Global corporate-level profiles of key companies operating within the North America Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Interventional Cardiology is segmented as follows -

  • Coronary Stents
  • Intravascular Ultrasound Systems (IVUS)
  • PTCA Balloon Catheters
  • Structural Heart Occlusion Devices
  • Transcatheter Accessories

Reasons to Buy

The North America Interventional Cardiology Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME21548CRDB

Table of Contents

1 Table of Contents

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Interventional Cardiology Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Interventional Cardiology Market, North America

  • 3.1 Interventional Cardiology Market, North America, Revenue ($m), 2018-2033
  • 3.2 Interventional Cardiology Market, North America, Revenue ($m), 2018-2033
  • 3.3 Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • 3.4 Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • 3.5 Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2024

4 Interventional Cardiology Market, Canada

  • 4.1 Interventional Cardiology Market, Canada, Revenue ($m), 2018-2033
    • 4.1.1 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2018-2033
    • 4.1.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2018-2033
    • 4.1.3 PTCA Balloon Catheters Market, Canada, Revenue ($m), by Segment, 2018-2033
    • 4.1.4 Structural Heart Occlusion Devices Market, Canada, Revenue ($m), by Segment, 2018-2033
    • 4.1.5 Transcatheter Accessories Market, Canada, Revenue ($m), by Segment, 2018-2033
  • 4.2 Interventional Cardiology Market, Canada, Volume (Units), 2018-2033
    • 4.2.1 Coronary Stents Market, Canada, Volume (Units), by Segment, 2018-2033
    • 4.2.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2018-2033
    • 4.2.3 PTCA Balloon Catheters Market, Canada, Volume (Units), by Segment, 2018-2033
    • 4.2.4 Structural Heart Occlusion Devices Market, Canada, Volume (Units), by Segment, 2018-2033
    • 4.2.5 Transcatheter Accessories Market, Canada, Volume (Units), by Segment, 2018-2033
  • 4.3 Interventional Cardiology Market, Canada, Average Price ($) , 2018-2033
  • 4.4 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2024

5 Interventional Cardiology Market, Mexico

  • 5.1 Interventional Cardiology Market, Mexico, Revenue ($m), 2018-2033
    • 5.1.1 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2018-2033
    • 5.1.2 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2018-2033
    • 5.1.3 PTCA Balloon Catheters Market, Mexico, Revenue ($m), by Segment, 2018-2033
    • 5.1.4 Structural Heart Occlusion Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033
    • 5.1.5 Transcatheter Accessories Market, Mexico, Revenue ($m), by Segment, 2018-2033
  • 5.2 Interventional Cardiology Market, Mexico, Volume (Units), 2018-2033
    • 5.2.1 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2018-2033
    • 5.2.2 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2018-2033
    • 5.2.3 PTCA Balloon Catheters Market, Mexico, Volume (Units), by Segment, 2018-2033
    • 5.2.4 Structural Heart Occlusion Devices Market, Mexico, Volume (Units), by Segment, 2018-2033
    • 5.2.5 Transcatheter Accessories Market, Mexico, Volume (Units), by Segment, 2018-2033
  • 5.3 Interventional Cardiology Market, Mexico, Average Price ($) , 2018-2033
  • 5.4 Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2024

6 Interventional Cardiology Market, United States

  • 6.1 Interventional Cardiology Market, United States, Revenue ($m), 2018-2033
    • 6.1.1 Coronary Stents Market, United States, Revenue ($m), by Segment, 2018-2033
    • 6.1.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2018-2033
    • 6.1.3 PTCA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
    • 6.1.4 Structural Heart Occlusion Devices Market, United States, Revenue ($m), by Segment, 2018-2033
    • 6.1.5 Transcatheter Accessories Market, United States, Revenue ($m), by Segment, 2018-2033
  • 6.2 Interventional Cardiology Market, United States, Volume (Units), 2018-2033
    • 6.2.1 Coronary Stents Market, United States, Volume (Units), by Segment, 2018-2033
    • 6.2.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2018-2033
    • 6.2.3 PTCA Balloon Catheters Market, United States, Volume (Units), by Segment, 2018-2033
    • 6.2.4 Structural Heart Occlusion Devices Market, United States, Volume (Units), by Segment, 2018-2033
    • 6.2.5 Transcatheter Accessories Market, United States, Volume (Units), by Segment, 2018-2033
  • 6.3 Interventional Cardiology Market, United States, Average Price ($) , 2018-2033
  • 6.4 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2024

7 Overview of Key Companies in North America Interventional Cardiology Market

  • 7.1 Boston Scientific Corp
    • 7.1.1 Company Overview
  • 7.2 Abbott Laboratories
    • 7.2.1 Company Overview
  • 7.3 Terumo Corp
    • 7.3.1 Company Overview
  • 7.4 Medtronic Plc
    • 7.4.1 Company Overview
  • 7.5 Koninklijke Philips NV
    • 7.5.1 Company Overview
  • 7.6 Asahi Intecc Co Ltd
    • 7.6.1 Company Overview
  • 7.7 Shockwave Medical Inc
    • 7.7.1 Company Overview
  • 7.8 Teleflex Inc
    • 7.8.1 Company Overview
  • 7.9 W. L. Gore & Associates Inc
    • 7.9.1 Company Overview
  • 7.10 AtriCure Inc
    • 7.10.1 Company Overview

8 Interventional Cardiology Market Pipeline Products

9 Recent Developments

  • 9.1 Corporate Communications
    • 9.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
    • 9.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
    • 9.1.3 Feb 18, 2025: Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
  • 9.2 Financial Announcements
    • 9.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
    • 9.2.2 Jul 30, 2025: AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
    • 9.2.3 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
    • 9.2.4 Mar 19, 2025: AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
    • 9.2.5 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
    • 9.2.6 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
    • 9.2.7 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
    • 9.2.8 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
    • 9.2.9 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
    • 9.2.10 Oct 08, 2024: AtriCure to Announce Third Quarter 2024 Financial Results
    • 9.2.11 Oct 03, 2024: AngioDynamics Announces Fiscal Year 2025 Q1 Results
    • 9.2.12 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
    • 9.2.13 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
  • 9.3 Government and Public Interest
    • 9.3.1 Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
    • 9.3.2 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept.
    • 9.3.3 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences
    • 9.3.4 Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
    • 9.3.5 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
    • 9.3.6 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
    • 9.3.7 Apr 24, 2025: Mabwell To Present Clinical Data of 9mw2821 Combined With Toripalimab in Patients With UC in an Oral Presentation at 2025 ASCO
    • 9.3.8 Mar 10, 2025: AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
    • 9.3.9 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
    • 9.3.10 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
    • 9.3.11 Nov 21, 2024: Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care
  • 9.4 Legal And Regulatory
    • 9.4.1 Aug 28, 2025: CNC Technologies Receives 510(K) Clearance For Duoblade Prime
    • 9.4.2 Apr 01, 2025: Domain Therapeutics To Present Data on DT-9081 at AACR Annual Meeting 2025
    • 9.4.3 Dec 09, 2024: Karolinska Development's Portfolio Company Modus Therapeutics Initiates a Phase 2 Study with Sevuparin for Treatment of CKD with Anemia
    • 9.4.4 Nov 19, 2024: Botanix presentation at Bell Potter Healthcare Conference
  • 9.5 Other Significant Developments
    • 9.5.1 Aug 13, 2025: Positron Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
    • 9.5.2 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
  • 9.6 Product News
    • 9.6.1 Jun 30, 2025: InterShunt Enrolls First Patient in New Heart Failure Study
    • 9.6.2 May 31, 2025: Daiichi Sankyo : ENHERTU Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel in Patients with Gastric Cancer in Phase 3 Trial
    • 9.6.3 Mar 04, 2025: Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
    • 9.6.4 Dec 09, 2024: Lomond Reports Results From Ongoing Clinical Studies of Lonitoclax, a Selective Bcl-2 Inhibitor in the Treatment of CLL and AML
    • 9.6.5 Dec 02, 2024: ProLynx Announces Publication of Its Once Monthly Semaglutide in the Proceedings of the National Academy of Sciences

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Coverage
    • 10.1.2 Secondary Research
    • 10.1.3 Primary Research
    • 10.1.4 Market Modeling and Forecasting
    • 10.1.5 Company Share Analysis
    • 10.1.6 Benchmarking
  • 10.2 GlobalData Consulting
  • 10.3 Contact Us
  • 10.4 Disclaimer
Product Code: GDME21548CRDB

List of Table

List of Tables

  • Table 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Interventional Cardiology Market, North America, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • Table 4: Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • Table 5: Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2024
  • Table 6: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 7: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 8: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 9: PTCA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Structural Heart Occlusion Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 11: Transcatheter Accessories Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Table 12: Interventional Cardiology Market, Canada, Volume (Units), 2018-2033
  • Table 13: Coronary Stents Market, Canada, Volume (Units), 2018-2033
  • Table 14: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2018-2033
  • Table 15: PTCA Balloon Catheters Market, Canada, Volume (Units), 2018-2033
  • Table 16: Structural Heart Occlusion Devices Market, Canada, Volume (Units), 2018-2033
  • Table 17: Transcatheter Accessories Market, Canada, Volume (Units), 2018-2033
  • Table 18: Interventional Cardiology Market, Canada, Average Price ($), 2018-2033
  • Table 19: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2024
  • Table 20: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 21: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 22: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 23: PTCA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 24: Structural Heart Occlusion Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 25: Transcatheter Accessories Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Table 26: Interventional Cardiology Market, Mexico, Volume (Units), 2018-2033
  • Table 27: Coronary Stents Market, Mexico, Volume (Units), 2018-2033
  • Table 28: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2018-2033
  • Table 29: PTCA Balloon Catheters Market, Mexico, Volume (Units), 2018-2033
  • Table 30: Structural Heart Occlusion Devices Market, Mexico, Volume (Units), 2018-2033
  • Table 31: Transcatheter Accessories Market, Mexico, Volume (Units), 2018-2033
  • Table 32: Interventional Cardiology Market, Mexico, Average Price ($), 2018-2033
  • Table 33: Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2024
  • Table 34: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 35: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 36: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 37: PTCA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 38: Structural Heart Occlusion Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 39: Transcatheter Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 40: Interventional Cardiology Market, United States, Volume (Units), 2018-2033
  • Table 41: Coronary Stents Market, United States, Volume (Units), 2018-2033
  • Table 42: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2018-2033
  • Table 43: PTCA Balloon Catheters Market, United States, Volume (Units), 2018-2033
  • Table 44: Structural Heart Occlusion Devices Market, United States, Volume (Units), 2018-2033
  • Table 45: Transcatheter Accessories Market, United States, Volume (Units), 2018-2033
  • Table 46: Interventional Cardiology Market, United States, Average Price ($), 2018-2033
  • Table 47: Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2024
  • Table 48: Interventional Cardiology Market Pipeline Products
  • Table 49: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

List of Figure

List of Figures

  • Figure 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Interventional Cardiology Market, North America, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • Figure 4: Interventional Cardiology Market, North America, Volume (Units), 2018-2033
  • Figure 5: Interventional Cardiology Market, North America, Company Share (%), 2024
  • Figure 6: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: PTCA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Structural Heart Occlusion Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 11: Transcatheter Accessories Market, Canada, Revenue ($m), USD Constant, 2018-2033
  • Figure 12: Interventional Cardiology Market, Canada, Volume (Units), 2018-2033
  • Figure 13: Coronary Stents Market, Canada, Volume (Units), 2018-2033
  • Figure 14: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2018-2033
  • Figure 15: PTCA Balloon Catheters Market, Canada, Volume (Units), 2018-2033
  • Figure 16: Structural Heart Occlusion Devices Market, Canada, Volume (Units), 2018-2033
  • Figure 17: Transcatheter Accessories Market, Canada, Volume (Units), 2018-2033
  • Figure 18: Interventional Cardiology Market, Canada, Company Share (%), 2024
  • Figure 19: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 20: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 21: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 22: PTCA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 23: Structural Heart Occlusion Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 24: Transcatheter Accessories Market, Mexico, Revenue ($m), USD Constant, 2018-2033
  • Figure 25: Interventional Cardiology Market, Mexico, Volume (Units), 2018-2033
  • Figure 26: Coronary Stents Market, Mexico, Volume (Units), 2018-2033
  • Figure 27: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2018-2033
  • Figure 28: PTCA Balloon Catheters Market, Mexico, Volume (Units), 2018-2033
  • Figure 29: Structural Heart Occlusion Devices Market, Mexico, Volume (Units), 2018-2033
  • Figure 30: Transcatheter Accessories Market, Mexico, Volume (Units), 2018-2033
  • Figure 31: Interventional Cardiology Market, Mexico, Company Share (%), 2024
  • Figure 32: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 33: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 34: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 35: PTCA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 36: Structural Heart Occlusion Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 37: Transcatheter Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 38: Interventional Cardiology Market, United States, Volume (Units), 2018-2033
  • Figure 39: Coronary Stents Market, United States, Volume (Units), 2018-2033
  • Figure 40: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2018-2033
  • Figure 41: PTCA Balloon Catheters Market, United States, Volume (Units), 2018-2033
  • Figure 42: Structural Heart Occlusion Devices Market, United States, Volume (Units), 2018-2033
  • Figure 43: Transcatheter Accessories Market, United States, Volume (Units), 2018-2033
  • Figure 44: Interventional Cardiology Market, United States, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!